Fulvestrant Chemical

Get a Price/Quote

Fulvestrant Chemical Specification

Molecular Weight
606.77 Grams (g)

Storage
Freezer

Place of Origin
China

Molecular Formula
C32H47F5O3S

Other Names
ICI 182,780;FULVESTRANT;FULVESTRANT-13C1-D2;FASLODEX;(7a,17b)-7-[9-[(4,4,5,5,5-pentafluoropentyl)sulfinyl]nonyl]estra-1,3,5(10)-triene-3,17-diol

CAS No
129453-61-8

Grade
Medicine Grade

Usage
Fulvestrant is used for the treatment of hormone receptor positive metastatic breast cancer or locally advanced unresectable disease in postmenopausal women; it is given by injection. A 2017 Cochrane review found it is as safe and effective as first line or second line endocrine therapy

Purity
98%min

Appearance
white solid

Application
Pharmaceutical Industry

Form
Solid

Fulvestrant Chemical Trade Information

Minimum Order Quantity
1 Ton

FOB Port
Shanghai

Payment Terms
Letter of Credit (L/C), Paypal, Letter of Credit at Sight (Sight L/C), Telegraphic Transfer (T/T)

Supply Ability
1000 Tons Per Week

Delivery Time
10 Days

Sample Available
Yes

Sample Policy
Contact us for information regarding our sample policy

Packaging Details
foil/bag/bottle

Main Export Market(s)
Australia, North America, Eastern Europe, Western Europe, Middle East, Africa, Central America, South America, Asia

About Fulvestrant Chemical

With our expertise in this domain, we are able to offer a superior grade Fulvestrant. These drugs are quality examined before delivery for the well-being of our customers. The medicine which we offer are widely demanded by hospitals and pharmaceutical industry for the treatment of various sickness. We formulate these drugs from high-grade chemicals and ingredient, brought from the reliable vendors of the market. The Fulvestrant is widely used in the market as these are non-allergic and very effective.

Product Details

CAS NO.: 129453-61-8
Molecular Formula: C₃₂H₄₇F₅O₃S
Molecular Weight: 606.77

Pharmaceutical Importance of Fulvestrant

Fulvestrant is primarily applied in the pharmaceutical industry, where it treats hormone receptor positive metastatic or locally advanced unresectable breast cancer in postmenopausal women. Its effectiveness and safety have been corroborated through medical reviews and clinical use, solidifying its role in modern oncology.

Key Specifications and Storage

Fulvestrant appears as a white solid, with a molecular weight of 606.77 grams and a formula of C32H47F5O3S. It is available at a high purity (98% minimum) and must be stored in a freezer to maintain stability and efficacy. These specifications ensure it meets the stringent demands of medicinal applications.

Distribution and Manufacturing

China is a major origin for Fulvestrant, with a variety of roles fulfilled by local suppliers, exporters, manufacturers, and traders. The compound is distributed widely in accordance with pharmaceutical standards and regulated for medical use. This broad supply network supports both domestic and international healthcare markets.

FAQs of Fulvestrant Chemical:

Q: How is fulvestrant administered for breast cancer treatment?

A: Fulvestrant is administered by injection, typically in a clinical setting, to treat hormone receptor positive metastatic breast cancer or locally advanced unresectable disease in postmenopausal women.

Q: What is the recommended storage condition for fulvestrant?

A: This compound should be stored in a freezer to preserve its stability and medicinal properties, ensuring its effectiveness upon usage.

Q: Where does fulvestrant originate and who supplies it?

A: Fulvestrant is primarily manufactured and distributed by companies in China, including various exporters, manufacturers, suppliers, and traders.

Q: When is fulvestrant used in therapy?

A: Fulvestrant can be used as a first-line or second-line endocrine therapy for hormone receptor positive metastatic breast cancer in postmenopausal women, according to medical guidance and clinical reviews.

Q: What process ensures the purity of fulvestrant?

A: Fulvestrant is refined to achieve a minimum purity of 98%, meeting strict pharmaceutical standards for medicine grade compounds, which is crucial for safe clinical application.

Q: What are the benefits of fulvestrant compared to other endocrine therapies?

A: A 2017 Cochrane review determined that fulvestrant is as safe and effective as other endocrine therapies for the treatment of hormone receptor positive metastatic breast cancer, making it a trusted choice in oncology.

Tell us about your requirement